Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -11.77%267.38K | -9.46%274.7K | -8.68%291.56K | -7.15%298.83K | -7.15%298.83K | -5.87%303.04K | -5.78%303.4K | -3.55%319.27K | -5.47%321.82K | -5.47%321.82K |
| -Cash and cash equivalents | -11.77%267.38K | -9.46%274.7K | -8.68%291.56K | -7.15%298.83K | -7.15%298.83K | -5.87%303.04K | -5.78%303.4K | -3.55%319.27K | -5.47%321.82K | -5.47%321.82K |
| Current deferred assets | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Total current assets | -11.77%267.38K | -9.46%274.7K | -8.68%291.56K | -7.15%298.83K | -7.15%298.83K | -5.87%303.04K | -5.78%303.4K | -3.55%319.27K | -5.47%321.82K | -5.47%321.82K |
| Non current assets | ||||||||||
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -11.77%267.38K | -9.46%274.7K | -8.68%291.56K | -7.15%298.83K | -7.15%298.83K | -5.87%303.04K | -5.78%303.4K | -3.55%319.27K | -5.47%321.82K | -5.47%321.82K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Current liabilities | -74.96%767 | 647.05%7.22K | 42.29%21.73K | 114.50%19.85K | 114.50%19.85K | 197.96%3.06K | -5.93%967 | 2,035.38%15.27K | 1.78%9.25K | 1.78%9.25K |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -74.96%767 | 647.05%7.22K | 42.29%21.73K | 114.50%19.85K | 114.50%19.85K | 197.96%3.06K | -5.93%967 | 2,035.38%15.27K | 1.78%9.25K | 1.78%9.25K |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | -4.30%406.23K | -4.30%406.23K | -4.30%406.23K | 0.00%406.23K | 0.00%406.23K |
| -common stock | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | 0.00%406.23K | -4.30%406.23K | -4.30%406.23K | -4.30%406.23K | 0.00%406.23K | 0.00%406.23K |
| Additional paid-in capital | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K | 0.00%80.79K |
| Retained earnings | -17.84%-220.41K | -18.93%-219.54K | -18.67%-217.18K | -19.26%-208.04K | -19.26%-208.04K | -1.44%-187.04K | -0.16%-184.59K | -4.60%-183.01K | -12.07%-174.45K | -12.07%-174.45K |
| Total stockholders'equity | -11.12%266.61K | -11.56%267.48K | -11.24%269.83K | -10.75%278.98K | -10.75%278.98K | -6.52%299.98K | -5.78%302.43K | -7.97%304.01K | -5.67%312.57K | -5.67%312.57K |
| Total equity | -11.12%266.61K | -11.56%267.48K | -11.24%269.83K | -10.75%278.98K | -10.75%278.98K | -6.52%299.98K | -5.78%302.43K | -7.97%304.01K | -5.67%312.57K | -5.67%312.57K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.